Qi-Ping Wei

551 total citations
37 papers, 412 citations indexed

About

Qi-Ping Wei is a scholar working on Molecular Biology, Clinical Biochemistry and Ophthalmology. According to data from OpenAlex, Qi-Ping Wei has authored 37 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Clinical Biochemistry and 7 papers in Ophthalmology. Recurrent topics in Qi-Ping Wei's work include Mitochondrial Function and Pathology (21 papers), ATP Synthase and ATPases Research (13 papers) and Metabolism and Genetic Disorders (13 papers). Qi-Ping Wei is often cited by papers focused on Mitochondrial Function and Pathology (21 papers), ATP Synthase and ATPases Research (13 papers) and Metabolism and Genetic Disorders (13 papers). Qi-Ping Wei collaborates with scholars based in China, United States and Singapore. Qi-Ping Wei's co-authors include Min‐Xin Guan, Xiangtian Zhou, Jia Qu, Fuxin Zhao, Yi Tong, Yanhong Sun, Li Yang, Juanjuan Zhang, Min Liang and Minglian Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Qi-Ping Wei

32 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi-Ping Wei China 13 370 204 45 25 23 37 412
Kamil S. Sitarz United Kingdom 7 176 0.5× 79 0.4× 14 0.3× 4 0.2× 3 0.1× 9 225
Tahira Sultan Saudi Arabia 13 109 0.3× 10 0.0× 258 5.7× 42 1.7× 10 0.4× 41 378
Alexandra A. Herzlich United States 10 157 0.4× 16 0.1× 181 4.0× 35 1.4× 15 0.7× 14 314
Puthiya M. Gopinath India 9 186 0.5× 9 0.0× 43 1.0× 9 0.4× 8 0.3× 13 249
Liza Douiev Israel 9 215 0.6× 80 0.4× 2 0.0× 9 0.4× 6 0.3× 13 298
Tomoyo Funayama Japan 11 133 0.4× 19 0.1× 188 4.2× 13 0.5× 5 0.2× 14 279
Taif A. Azad Saudi Arabia 12 98 0.3× 10 0.0× 256 5.7× 35 1.4× 5 0.2× 40 347
Joseph L. Wilkerson United States 7 239 0.6× 9 0.0× 13 0.3× 31 1.2× 6 0.3× 12 288
Sam Khandhadia United Kingdom 6 175 0.5× 16 0.1× 323 7.2× 15 0.6× 6 0.3× 8 429
Víctor Raggio Uruguay 7 112 0.3× 11 0.1× 35 0.8× 4 0.2× 8 0.3× 29 207

Countries citing papers authored by Qi-Ping Wei

Since Specialization
Citations

This map shows the geographic impact of Qi-Ping Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi-Ping Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi-Ping Wei more than expected).

Fields of papers citing papers by Qi-Ping Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi-Ping Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi-Ping Wei. The network helps show where Qi-Ping Wei may publish in the future.

Co-authorship network of co-authors of Qi-Ping Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Qi-Ping Wei. A scholar is included among the top collaborators of Qi-Ping Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi-Ping Wei. Qi-Ping Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Qi-Ping, et al.. (2023). Treating Severe Adverse Drug Reactions Caused by Ischemic Optic Neuropathy with Ginkgo Biloba Extract Injection: A Case Report.. PubMed. 29(5). 78–81. 1 indexed citations
2.
Zhou, Huan, et al.. (2023). Medication Rules and Mechanism of Topical Traditional Chinese Medicine for Meibomian Gland Dysfunction-Related Dry Eye Disease.. PubMed. 29(7). 126–132. 2 indexed citations
3.
Zhao, Yuwei, et al.. (2023). Effects of acupuncture on age-related macular degeneration: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 18(3). e0283375–e0283375. 3 indexed citations
4.
Wu, Qiong, et al.. (2022). Optic nerve injury models under varying forces. International Ophthalmology. 43(3). 757–769. 3 indexed citations
5.
Yan, Xiaoling, et al.. (2020). Clinical efficacy analysis of Qing Mang Yi Hao in the treatment of toxic optic atrophy. SHILAP Revista de lepidopterología.
6.
Tong, Louis, Hla Myint Htoon, Aihua Hou, et al.. (2018). Acupuncture and herbal formulation compared with artificial tears alone: evaluation of dry eye symptoms and associated tests in randomised clinical trial. BMJ Open Ophthalmology. 3(1). e000150–e000150. 14 indexed citations
7.
Ji, Yanchun, Xiaoyang Liang, Ling Zhu, et al.. (2017). Leber's hereditary optic neuropathy is potentially associated with a novel m.5587T>C mutation in two pedigrees. Molecular Medicine Reports. 16(6). 8997–9004. 11 indexed citations
8.
Ma, Jinli, et al.. (2016). Clinical evaluation of Ginkgo biloba extract for diabetic retinopathy. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Ma, Jinli, et al.. (2016). Efficacy of Chinese medicine formula for central serous chorioretinopathy. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Gong, Xiaohong, et al.. (2015). Associations of polymorphisms of rs1015213 with primary angle closure glaucoma-recent evidence and a meta-analysis.. PubMed Central. 8(7). 10804–14. 1 indexed citations
11.
Wei, Qi-Ping, et al.. (2014). 視神経萎縮に及ぼす眼とFengchi(GB20)周辺の3経穴における針の治療効果【Powered by NICT】. 37(6). 420–423. 1 indexed citations
12.
Ji, Yanchun, Min Liang, Juanjuan Zhang, et al.. (2014). Mitochondrial haplotypes may modulate the phenotypic manifestation of the LHON-associated ND1 G3460A mutation in Chinese families. Journal of Human Genetics. 59(3). 134–140. 17 indexed citations
13.
Zhang, Juanjuan, Pingping Jiang, Xiaofen Jin, et al.. (2014). Leber's hereditary optic neuropathy caused by the homoplasmic ND1 m.3635G>A mutation in nine Han Chinese families. Mitochondrion. 18. 18–26. 27 indexed citations
14.
Zhang, Yongmei, Yanchun Ji, Xiaoling Liu, et al.. (2010). Leber's hereditary optic neuropathy may be associated with the mitochondrial tRNA<SUP>Glu</SUP> A14693G mutation in three Chinese families. Hereditas (Beijing). 32(4). 353–359. 2 indexed citations
15.
Zhao, Fuxin, Xiangtian Zhou, Ming Liang, et al.. (2009). Leber’s hereditary optic neuropathy is associated with mitochondrial ND6 T14502C mutation. Biochemical and Biophysical Research Communications. 389(3). 466–472. 29 indexed citations
16.
Qu, Jia, Xiangtian Zhou, Fuxin Zhao, et al.. (2009). Low penetrance of Leber's hereditary optic neuropathy in ten Han Chinese families carrying the ND6 T11484C mutation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1800(3). 305–312. 15 indexed citations
17.
Tong, Yi, Yanhong Sun, Xiangtian Zhou, et al.. (2009). Very low penetrance of Leber’s hereditary optic neuropathy in five Han Chinese families carrying the ND1 G3460A mutation. Molecular Genetics and Metabolism. 99(4). 417–424. 12 indexed citations
18.
Wei, Qi-Ping, Xiangtian Zhou, Li Yang, et al.. (2007). The coexistence of mitochondrial ND6 T14484C and 12S rRNA A1555G mutations in a Chinese family with Leber’s hereditary optic neuropathy and hearing loss. Biochemical and Biophysical Research Communications. 357(4). 910–916. 21 indexed citations
19.
Sun, Yanhong, Qi-Ping Wei, Xiangtian Zhou, et al.. (2006). Leber’s hereditary optic neuropathy is associated with the mitochondrial ND6 T14484C mutation in three Chinese families. Biochemical and Biophysical Research Communications. 347(1). 221–225. 13 indexed citations
20.
Zhou, Xiangtian, Qi-Ping Wei, Li Yang, et al.. (2005). Leber’s hereditary optic neuropathy is associated with the mitochondrial ND4 G11696A mutation in five Chinese families. Biochemical and Biophysical Research Communications. 340(1). 69–75. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamil S. Sitarz Breakdown of academic impact, for papers by Tahira Sultan Breakdown of academic impact, for papers by Alexandra A. Herzlich Breakdown of academic impact, for papers by Puthiya M. Gopinath Breakdown of academic impact, for papers by Liza Douiev Breakdown of academic impact, for papers by Tomoyo Funayama Breakdown of academic impact, for papers by Taif A. Azad Breakdown of academic impact, for papers by Joseph L. Wilkerson Breakdown of academic impact, for papers by Sam Khandhadia Breakdown of academic impact, for papers by Víctor Raggio
Rankless by CCL
2026